163 related articles for article (PubMed ID: 25706089)
21. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Kapur S; Zipursky RB; Remington G
Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
[TBL] [Abstract][Full Text] [Related]
22. Stimulating DDX3 expression by serotonin 5-HT receptor 7 through phosphorylation of p53 via the AC-PKA-ERK signaling pathway.
Kang LJ; Nguyen KVA; Eom S; Choi YJ; Nguyen CN; Lee J; Kim C; Lee S; Lee SG; Lee JH
J Cell Biochem; 2019 Oct; 120(10):18193-18208. PubMed ID: 31172579
[TBL] [Abstract][Full Text] [Related]
23. The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency.
Schreiber S; Getslev V; Backer MM; Weizman R; Pick CG
Pharmacol Biochem Behav; 1999 Sep; 64(1):75-80. PubMed ID: 10495000
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
Deveney AM; Waddington JL
Psychopharmacology (Berl); 1996 Mar; 124(1-2):40-9. PubMed ID: 8935799
[TBL] [Abstract][Full Text] [Related]
25. Radioreceptor binding profile of the atypical antipsychotic olanzapine.
Bymaster FP; Calligaro DO; Falcone JF; Marsh RD; Moore NA; Tye NC; Seeman P; Wong DT
Neuropsychopharmacology; 1996 Feb; 14(2):87-96. PubMed ID: 8822531
[TBL] [Abstract][Full Text] [Related]
26. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
Cussac D; Duqueyroix D; Newman-Tancredi A; Millan MJ
Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of olanzapine substitution in rats discriminating clozapine by the D2/3 agonist quinpirole.
Cole JC; Field M; Sumnall HR; Goudie AJ
Behav Pharmacol; 2007 May; 18(3):185-90. PubMed ID: 17426482
[TBL] [Abstract][Full Text] [Related]
28. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature.
Shahid M; Walker GB; Zorn SH; Wong EH
J Psychopharmacol; 2009 Jan; 23(1):65-73. PubMed ID: 18308814
[TBL] [Abstract][Full Text] [Related]
29. Allosteric Inhibition of Serotonin 5-HT
Satała G; Duszyńska B; Lenda T; Nowak G; Bojarski AJ
Mol Neurobiol; 2018 Apr; 55(4):2897-2910. PubMed ID: 28455702
[TBL] [Abstract][Full Text] [Related]
30. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating.
Bubeníková V; Votava M; Horácek J; Pálenícek T; Dockery C
Pharmacol Biochem Behav; 2005 Apr; 80(4):591-6. PubMed ID: 15820528
[TBL] [Abstract][Full Text] [Related]
31. Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia.
Newman-Tancredi A; Assié MB; Leduc N; Ormière AM; Danty N; Cosi C
Int J Neuropsychopharmacol; 2005 Sep; 8(3):341-56. PubMed ID: 15707540
[TBL] [Abstract][Full Text] [Related]
32. Clozapine and olanzapine inhibit proton currents in BV2 microglial cells.
Shin H; Kim J; Song JH
Eur J Pharmacol; 2015 May; 755():74-9. PubMed ID: 25771455
[TBL] [Abstract][Full Text] [Related]
33. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
[TBL] [Abstract][Full Text] [Related]
34. The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55.
Kargl J; Balenga NA; Platzer W; Martini L; Whistler JL; Waldhoer M
Br J Pharmacol; 2012 Apr; 165(8):2611-9. PubMed ID: 21718301
[TBL] [Abstract][Full Text] [Related]
35. Clozapine downregulates 5-hydroxytryptamine6 (5-HT6) and upregulates 5-HT7 receptors in HeLa cells.
Zhukovskaya NL; Neumaier JF
Neurosci Lett; 2000 Jul; 288(3):236-40. PubMed ID: 10889351
[TBL] [Abstract][Full Text] [Related]
36. Novel insights on the structural determinants of clozapine and olanzapine multi-target binding profiles.
Selent J; Marti-Solano M; Rodríguez J; Atanes P; Brea J; Castro M; Sanz F; Loza MI; Pastor M
Eur J Med Chem; 2014 Apr; 77():91-5. PubMed ID: 24631727
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug.
Bymaster FP; Rasmussen K; Calligaro DO; Nelson DL; DeLapp NW; Wong DT; Moore NA
J Clin Psychiatry; 1997; 58 Suppl 10():28-36. PubMed ID: 9265914
[TBL] [Abstract][Full Text] [Related]
38. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms.
Lovenberg TW; Baron BM; de Lecea L; Miller JD; Prosser RA; Rea MA; Foye PE; Racke M; Slone AL; Siegel BW
Neuron; 1993 Sep; 11(3):449-58. PubMed ID: 8398139
[TBL] [Abstract][Full Text] [Related]
39. Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.
Newman-Tancredi A; Rivet JM; Cussac D; Touzard M; Chaput C; Marini L; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):188-99. PubMed ID: 12923612
[TBL] [Abstract][Full Text] [Related]
40. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
Rollema H; Lu Y; Schmidt AW; Sprouse JS; Zorn SH
Biol Psychiatry; 2000 Aug; 48(3):229-37. PubMed ID: 10924666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
